Case Studies
cost-effective hit-finding projects
Cresset works with clients to find new hits for their discovery projects using our field-based software. Projects take on average two to four weeks and we do not ask for IP. Cresset's FieldScreen™ virtual screening software has been used by us in over 30 hit-finding projects against a wide variety of targets and has a current success rate of finding good novel hit compounds of ~80%. Some of the projects we have worked on include:
| Client | Target Class | Outcome | Notes |
|---|---|---|---|
| Large Pharma | Chemokine receptor | Success | 3 diverse series progressed |
| Large Pharma | Enzyme | Success | Comparison with in-house and competitor methods |
| Biotech | GPCR | Success | 30% hit rate |
| Large Pharma | Protease | Fail | Looking for less basic mimics of highly basic compounds |
| Biotech | Metalloprotease | Fail | No novel metal chelators in database |
| Biotech | Kinase | Success | >25% hit rate, <60 compounds screened |
| Biotech | Ion channel | Success | 30% hit rate, ~300 compounds screened |
| Biotech | Ion channel | Success | 10% hit rate |
| Biotech | Unknown | Success | Good hit rate |
| James Black Foundation | CCK2 | Success | 30% hit rate |
| Biotech | GPCR | Success | >25% hit rate |
| Biotech | Protease | Fail | Primary amine required for activity |
| Biotech | GPCR | Success | Undisclosed hit rate |
| Biotech | CNS target | Success | Undisclosed hit rate |
| Wellcome Trust and Edinburgh University | 11β-HSD1 | Success | 10% hit rate, 3 new series found |
| Biotech | Undisclosed | Success | Undisclosed hit rate |
Some representative case studies are:
- CCK2: a popular peptide-ligand GPCR target
- Cresset determined the bound conformation using FieldTemplater™, selected compounds for testing and found multiple lead series after screening only 88 compound
- 11beta HSD1: a steroid receptor
- Virtual screening using the fields of the natural ligand produced 23 hits in 4 series from screening 408 compounds
- A peptide-ligand GPCR with no known small molecule inhibitors
- Cresset started with the 30-amino-acid natural ligand, created a template from a key 4 residue segment and found 12 hits out of 41 purchased compounds
We also provide support for hit-to-lead and lead optimization projects.
+44(0)1707 356120